on OXURION (EBR:OXUR)
Oxurion reports transparency of Atlas Special Opportunities II LLC
Leuven, Belgium – On February 19, 2026, Oxurion NV, a company listed on Euronext Brussels, announced that it had received a transparency statement from Atlas Special Opportunities II LLC. According to this statement, as of February 16, 2026, Atlas held 3,458,157 Oxurion shares, representing a decrease below the 5% threshold of the total share capital of 70,098,394 shares following the sale of voting rights.
Oxurion, based in Leuven, specializes in acquiring majority stakes in promising European pharmaceutical contract manufacturers. The company aims to build an integrated group to serve the healthcare sector.
The statement also warns of the risks associated with planned investments in digital assets, such as Bitcoin and Ethereum, which could affect anticipated returns due to volatility and uncertain regulations.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news